First Opinion By Dorothy Pomerantz 23andMe had devastating news about my health. I wish a person had delivered it
Exclusive By Damian Garde Lavishly funded Moderna hits safety problems in bold bid to revolutionize medicine
First Opinion By Warren A. Whyte Racial disparities in Covid-19 are bad. They’re even worse in cancer
In the Lab By Shraddha Chakradhar Elevated stress hormone levels could reawaken dormant cancer cells, study finds
First Opinion By Ted Okon Trump’s ‘most favored nations’ experiment undermines care for millions covered by Medicare
Health By Elizabeth Cooney New cancer patients — especially Black people — are more susceptible to severe Covid-19 infections
Something Ventured By Kate Sheridan Triplet Therapeutics and three other startups got venture funding a year ago. Where are they now?
Biotech By Adam Feuerstein The biotech scorecard for the first quarter: 17 stock-moving events to watch
Biotech By Adam Feuerstein Agios sells cancer business to French drug maker for up to $2 billion, will now focus on inherited diseases
Health By Elizabeth Cooney Covid-19 surge could lead to another drop in patient visits, doctors fear — and more missed pediatric cancers
Health By Usha Lee McFarling ‘Why would we ever go back?’: Covid-driven shift to remote cancer clinical trials will likely outlast the pandemic
Biotech By Matthew Herper With new data and a storied history, Eli Lilly’s blood cancer pill is looking stronger
STAT China By Jonathan Chan Legend Biotech believes it is not a target of Chinese investigation, CEO says
Biotech By Eric Boodman ‘How are we going to get on that plane?’: The transatlantic race to deliver CAR-T cancer therapy during the pandemic
Heavyweights By Eric Boodman As a kid, his factory work paid for his dad’s cancer care. As an oncologist, his research offers more than survival
First Opinion By Linda S. Birnbaum and Margaret L. Kripke The National Cancer Institute needs to publish information about chemical exposure and cancer risk
In the Lab By Elizabeth Cooney Cancer vaccine cocktail boosts immune response after melanoma surgery, research shows
First Opinion By Ravi Parikh, Christopher Manz, and Mitesh Patel A nudge helps doctors bring up end-of-life issues with their dying cancer patients
Health By Priyanka Runwal Cancer clinical trial enrollment has plummeted. Will patients come back amid Covid-19?
First Opinion By Jessica Stuart I was a ‘nonadherent’ patient. That’s made me a more empathetic doctor
Health By Priyanka Runwal After a breast cancer diagnosis, many Black women face barriers that delay their care
In the Lab By Elizabeth Cooney Training the innate immune system to thwart cancer could open door to a new therapy
Health By Nicholas St. Fleur Colorectal cancer screening should start five years earlier — at 45 — expert panel says
Biotech By Adam Feuerstein Mirati study results set new response bar for KRAS-blocking lung cancer drugs
Pharma By Rebecca Ritzel FDA pushes drug companies to include younger people in breast cancer drug trials
First Opinion By Zachary A.K. Frosch, Lawrence N. Shulman, and Justin E. Bekelman 3 ways to counter Covid-19’s threat to community-based cancer care
Biotech By Adam Feuerstein CRISPR Therapeutics’ CAR-T treatment shows encouraging results, but one death is tied to therapy